Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study

Autor: Chukwurah, Ijeoma, Haq, Sulaimaan, Lo, Jonathan, Shah, Parita, Wilken-Smith, Stephanie, Ramanathan, Anitha, Patel, Mikin, Romanczuk, Lidia, King, Rebecca, Domingo, Jason, Shamtally, Djamila, Mendoza, Vivien, Sanchez, Joanne, Stark, Hannah, Knight, Bridget, Bee, Louise, Estember, Charmaine, Barnes, Anna, Watkins, Darcy, Stone, Sam, Kirkwood, John, Parkinson, Marian, Gardner-Thorpe, Helen, Covil, Kate, Derikx, Lauranne, Alcalde, Beatriz Gros, Lee, Irish, Cipriano, Bessie, Ruocco, Giuseppe, Baden, Manisha, Cooke, Graham, Kourampa, Evgenia, Pasquale, Ciro, Robisco-Diaz, Elena, Bhatti, Suhaylah, Liu, Zhigang, Alexander, James L., Le, Kaixing, Zhou, Xin, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Lin, Kathy Weitung, McFarlane, Leon R., Constable, Laura, Seoane, Rocio Castro, Anand, Nikhil, Bewshea, Claire, Nice, Rachel, D'Mello, Andrea, Jones, Gareth R., Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M., Hicks, Lucy C., Williams, Horace RT., Kent, Alexandra J., Linger, Rachel, Parkes, Miles, Kok, Klaartje, Patel, Kamal V., Teare, Julian P., Altmann, Daniel M., Boyton, Rosemary J., Hart, Ailsa L., Lees, Charlie W., Goodhand, James R., Kennedy, Nicholas A., Pollock, Katrina M., Ahmad, Tariq, Powell, Nick
Zdroj: In eClinicalMedicine October 2023 64
Databáze: ScienceDirect